Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 147, Issue -, Pages 112662
Publisher
Elsevier BV
Online
2022-01-25
DOI
10.1016/j.biopha.2022.112662
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitors
- (2021) Neil T. Conlon et al. BRITISH JOURNAL OF CANCER
- Epigenetic Silencing of HER2 Expression during Epithelial-Mesenchymal Transition Leads to Trastuzumab Resistance in Breast Cancer
- (2021) Babak Nami et al. Life-Basel
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Decitabine Response in Breast Cancer Requires Efficient Drug Processing and Is Not Limited by Multidrug Resistance
- (2020) Margaret L. Dahn et al. MOLECULAR CANCER THERAPEUTICS
- Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network
- (2020) Xiaorong Gu et al. LEUKEMIA
- Evolving standards of care and new challenges in the management of HER2‐positive breast cancer
- (2020) Grace M. Choong et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Abnormal Ferroptosis in Myelodysplastic Syndrome
- (2020) Qi Lv et al. Frontiers in Oncology
- Epigenetics in Breast Cancer Therapy—New Strategies and Future Nanomedicine Perspectives
- (2020) Verona Buocikova et al. Cancers
- Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise
- (2019) Daphné Morel et al. Nature Reviews Clinical Oncology
- Effects of 5-Aza-2′-deoxycytidine (decitabine) on gene expression
- (2018) Ratnam S. Seelan et al. DRUG METABOLISM REVIEWS
- Dual IRE1 RNase functions dictate glioblastoma development
- (2018) Stéphanie Lhomond et al. EMBO Molecular Medicine
- DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine
- (2018) Jia Yu et al. JOURNAL OF CLINICAL INVESTIGATION
- Epigenetic therapy: azacytidine and decitabine in acute myeloid leukemia
- (2018) Stephan R. Bohl et al. Expert Review of Hematology
- Recent Advances in the Treatment of Breast Cancer
- (2018) Christy W. S. Tong et al. Frontiers in Oncology
- The Gene Ontology Resource: 20 years and still GOing strong
- (2018) NUCLEIC ACIDS RESEARCH
- Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources
- (2018) Sebastian Köhler et al. NUCLEIC ACIDS RESEARCH
- Voltage-gated calcium channels: Novel targets for cancer therapy
- (2017) Nam Nhut Phan et al. Oncology Letters
- Cytidine Deaminase Deficiency Reveals New Therapeutic Opportunities against Cancer
- (2016) Hamza Mameri et al. CLINICAL CANCER RESEARCH
- In vitrogenotoxicity testing of four reference metal nanomaterials, titanium dioxide, zinc oxide, cerium oxide and silver: towards reliable hazard assessment
- (2016) Naouale El Yamani et al. MUTAGENESIS
- A novel apoptosis-inducing mechanism of 5-aza-2′-deoxycitidine in melanoma cells: Demethylation of TNF-α and activation of FOXO1
- (2015) Shunsuke Noguchi et al. CANCER LETTERS
- Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells
- (2015) Shi-Yong Li et al. JOURNAL OF CONTROLLED RELEASE
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- genomation: a toolkit to summarize, annotate and visualize genomic intervals
- (2014) A. Akalin et al. BIOINFORMATICS
- Decitabine Induces Delayed Reactive Oxygen Species (ROS) Accumulation in Leukemia Cells and Induces the Expression of ROS Generating Enzymes
- (2014) Tamer E. Fandy et al. CLINICAL CANCER RESEARCH
- Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
- (2013) Baoxu Pang et al. Nature Communications
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
- (2012) Hsing-Chen Tsai et al. CANCER CELL
- Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin)
- (2012) Cristina Oliveras-Ferraros et al. CELL CYCLE
- Decitabine, a DNA methyltransferase inhibitor, induces apoptosis in human leukemia cells through intracellular reactive oxygen species generation
- (2012) DONG YEOK SHIN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine
- (2011) Ferda Ari et al. CELL BIOCHEMISTRY AND FUNCTION
- DNMT3B gene amplification predicts resistance to DNA demethylating drugs
- (2011) Laia Simó-Riudalbas et al. GENES CHROMOSOMES & CANCER
- GOrevenge: A Novel Generic Reverse Engineering Method for the Identification of Critical Molecular Players, Through the Use of Ontologies
- (2011) K. Moutselos et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents
- (2010) Sameer Mirza et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The mammalian phenotype ontology: enabling robust annotation and comparative analysis
- (2009) Cynthia L. Smith et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Anthracycline-trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies
- (2008) D. Rayson et al. ANNALS OF ONCOLOGY
- Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer
- (2008) P. D. Ottewell et al. JNCI-Journal of the National Cancer Institute
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now